# Encapsulation and Functional Activity of Lactobacillus reuteri Strains: Advances, Challenges, and Perspectives

**Authors:** León‐Espinosa Erika Berenice, Barrios‐Francisco Rigoberto, Colin‐Molina Abraham, Martínez‐Palma Nikte Yoliztli, Rentería‐Ortega Minerva

PMC · DOI: 10.1111/1541-4337.70412 · Comprehensive Reviews in Food Science and Food Safety · 2026-02-24

## TL;DR

This paper reviews the functional benefits and encapsulation strategies for Limosilactobacillus reuteri, a probiotic with potential health benefits, and highlights challenges in its stability and application.

## Contribution

The paper provides a comprehensive review of L. reuteri's functional properties and encapsulation methods, emphasizing strain-specific effects and future research needs.

## Key findings

- L. reuteri exhibits immunomodulatory, antimicrobial, and anti-inflammatory properties.
- Encapsulation methods like ionic gelation and electrospray improve strain survival during processing.
- Strain-specific factors and coating materials influence release kinetics and viability.

## Abstract

Over the past decade, probiotics have gone from been special health supplements to widely incorporated components in many foods and nutrition products. This has led to more careful checks of their safety, viability, and functional performance under realistic processing and consumption conditions. Within lactic acid bacteria, Limosilactobacillus reuteri (formerly Lactobacillus reuteri) has been extensively investigated for its immunomodulatory, antimicrobial, anti‐inflammatory, antioxidant, and metabolic properties as demonstrated across multiple in vivo and in vitro experimental models. Despite these functional attributes, its viability during food processing and gastrointestinal transit remains strongly influenced by the strain and the characteristics of the delivery matrix; as a result, encapsulation is an essential strategy to preserve cellular integrity and functionality. The present review examines the functional properties of Limosilactobacillus reuteri (L. reuteri or LR) strains alongside the technological approaches used for their encapsulation. Current encapsulation approaches, including ionic gelation, extrusion, electrospray, and spray drying combined with biopolymers to improve encapsulation efficiency and survival of strains such as DSM 17938 and DSM 20016, are discussed with emphasis on their applicability to probiotic delivery and the formulation of functional foods with potential to improve gastrointestinal health, modulate inflammation, and enhance metabolic functions. In addition to strain‐specific functional activities, this review examines how coating material, processing method, and strain affect release kinetics, functional activities, and viability. However, data on the stability of encapsulated L. reuteri during industrial processing, storage, and health claim validation under regulatory frameworks remain limited. Future research should address these challenges to support the use of L. reuteri in functional foods and therapeutic products.

## Linked entities

- **Species:** Limosilactobacillus reuteri (taxon 1598)

## Full-text entities

- **Diseases:** hemolytic (MESH:D006461), metabolic disorder (MESH:D008659), diarrhea (MESH:D003967), weight gain (MESH:D015430), Obesity (MESH:D009765), nonalcoholic fatty liver disease (MESH:D065626), plaque (MESH:D003773), inflammation (MESH:D007249), degenerative diseases (MESH:D019636), ulcerative colitis (MESH:D003093), gingival bleeding (MESH:D005884), chronic (MESH:D002908), rotavirus infection (MESH:D012400), periodontal diseases (MESH:D010510), HPI (MESH:D009366), adiposity (MESH:D018205), toxicity (MESH:D064420), gingivitis (MESH:D005891), insulin resistance (MESH:D007333), infections (MESH:D007239), Crohn's disease (MESH:D003424), indeterminate colitis (MESH:D003092), GITS (MESH:D005767)
- **Chemicals:** cholesterol (MESH:D002784), xanthan (MESH:C002563), Inulin (MESH:D007444), ascorbic acid (MESH:D001205), reutericyclin (MESH:C416127), free radical (MESH:D005609), waxes (MESH:D014885), triglyceride (MESH:D014280), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), polymers (MESH:D011108), Reuterin (MESH:C047158), pectin (MESH:D010368), polysaccharides (MESH:D011134), lactose (MESH:D007785), chitosan (MESH:D048271), maltodextrin (MESH:C008315), acid (MESH:D000143), oxygen (MESH:D010100), Alginate (MESH:D000464), glucose (MESH:D005947), gellan (MESH:C048288), hydrogen (MESH:D006859), magnesium oxide (MESH:D008277), lipid (MESH:D008055), 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (MESH:C002502), fructose (MESH:D005632), DPC (MESH:C000607942), prebiotics (MESH:D056692), starch (MESH:D013213), hydroxyapatite (MESH:D017886), Sodium (MESH:D012964), glycerol (MESH:D005990), polydextrose (MESH:C033375), alginate-konjac gum (-), bisphenol (MESH:C543008), bile salts (MESH:D001647)
- **Species:** Penicillium digitatum (species) [taxon 36651], Rubroshorea almon (species) [taxon 292004], Mangifera indica (mango, species) [taxon 29780], Limosilactobacillus reuteri subsp. reuteri (subspecies) [taxon 557436], Lacticaseibacillus rhamnosus (species) [taxon 47715], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Pseudomonas aeruginosa (species) [taxon 287], Escherichia coli (E. coli, species) [taxon 562], Bacillus cereus (species) [taxon 1396], Streptococcus mutans (species) [taxon 1309], Clostridium perfringens (species) [taxon 1502], Limosilactobacillus reuteri (species) [taxon 1598], Clostridium sp. ATCC 29733 (species) [taxon 1507], Fusarium oxysporum (species) [taxon 5507], Streptococcus agalactiae (species) [taxon 1311], Colletotrichum gloeosporioides (species) [taxon 474922], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Staphylococcus aureus (species) [taxon 1280], Helicobacter pylori (species) [taxon 210], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Listeria monocytogenes (species) [taxon 1639], Powellomyces sp. EA (species) [taxon 252690]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930331/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930331/full.md

## References

136 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930331/full.md

---
Source: https://tomesphere.com/paper/PMC12930331